Literature DB >> 2787923

Analytical study of a Rift Valley fever epidemic.

A Jouan1, I Coulibaly, F Adam, B Philippe, O Riou, B Leguenno, R Christie, N Ould Merzoug, T Ksiazek, J P Digoutte.   

Abstract

Three epidemiological investigations were carried out during and after the 1987 Rift Valley fever (RVF) epidemic in South Mauritania: a case control study, a cross-sectional study in the town of Rosso and a cross-sectional study of villages and encampments around Rosso. The case control study showed an association between epizootic and epidemic outbreaks. The study in Rosso town showed housing and district effects. Also, a medical survey of hospital staff showed the absence of interhuman contamination. The cross-sectional study of villages and encampments around Rosso showed heterogeneity corresponding to a village and ethnic effect. The human epidemic was linked to epizootic disease, but the "vectors" of the disease are not as yet known.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2787923     DOI： 10.1016/s0923-2516(89)80096-2

Source DB:  PubMed          Journal:  Res Virol        ISSN： 0923-2516


  9 in total

1.  Risk factors for severe Rift Valley fever infection in Kenya, 2007.

Authors:  Amwayi S Anyangu; L Hannah Gould; Shahnaaz K Sharif; Patrick M Nguku; Jared O Omolo; David Mutonga; Carol Y Rao; Edith R Lederman; David Schnabel; Janusz T Paweska; Mark Katz; Allen Hightower; M Kariuki Njenga; Daniel R Feikin; Robert F Breiman
Journal:  Am J Trop Med Hyg       Date:  2010-08       Impact factor: 2.345

2.  An outbreak of Rift Valley fever in Northeastern Kenya, 1997-98.

Authors:  Christopher W Woods; Adam M Karpati; Thomas Grein; Noel McCarthy; Peter Gaturuku; Eric Muchiri; Lee Dunster; Alden Henderson; Ali S Khan; Robert Swanepoel; Isabelle Bonmarin; Louise Martin; Philip Mann; Bonnie L Smoak; Michael Ryan; Thomas G Ksiazek; Ray R Arthur; Andre Ndikuyeze; Naphtali N Agata; Clarence J Peters
Journal:  Emerg Infect Dis       Date:  2002-02       Impact factor: 6.883

3.  Vaccination with DNA plasmids expressing Gn coupled to C3d or alphavirus replicons expressing gn protects mice against Rift Valley fever virus.

Authors:  Nitin Bhardwaj; Mark T Heise; Ted M Ross
Journal:  PLoS Negl Trop Dis       Date:  2010-06-22

4.  Rift valley fever virus lacking the NSs and NSm genes is highly attenuated, confers protective immunity from virulent virus challenge, and allows for differential identification of infected and vaccinated animals.

Authors:  Brian H Bird; César G Albariño; Amy L Hartman; Bobbie Rae Erickson; Thomas G Ksiazek; Stuart T Nichol
Journal:  J Virol       Date:  2008-01-16       Impact factor: 5.103

5.  Ecological distribution and population dynamics of Rift Valley fever virus mosquito vectors (Diptera, Culicidae) in Senegal.

Authors:  Biram Biteye; Assane G Fall; Mamadou Ciss; Momar T Seck; Andrea Apolloni; Moussa Fall; Annelise Tran; Geoffrey Gimonneau
Journal:  Parasit Vectors       Date:  2018-01-09       Impact factor: 3.876

Review 6.  Current Status of Rift Valley Fever Vaccine Development.

Authors:  Bonto Faburay; Angelle Desiree LaBeaud; D Scott McVey; William C Wilson; Juergen A Richt
Journal:  Vaccines (Basel)       Date:  2017-09-19

7.  Choice of inbred rat strain impacts lethality and disease course after respiratory infection with Rift Valley Fever Virus.

Authors:  Jacquelyn M Bales; Diana S Powell; Laura M Bethel; Douglas S Reed; Amy L Hartman
Journal:  Front Cell Infect Microbiol       Date:  2012-08-02       Impact factor: 5.293

8.  Inflammatory Biomarkers Associated with Lethal Rift Valley Fever Encephalitis in the Lewis Rat Model.

Authors:  Amy L Caroline; Michael R Kujawa; Tim D Oury; Douglas S Reed; Amy L Hartman
Journal:  Front Microbiol       Date:  2016-01-07       Impact factor: 5.640

9.  Short Interfering RNA Inhibits Rift Valley Fever Virus Replication and Degradation of Protein Kinase R in Human Cells.

Authors:  Bonto Faburay; Juergen A Richt
Journal:  Front Microbiol       Date:  2016-11-24       Impact factor: 5.640
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.